🇺🇸

Corporate Governance

· daily

US Corporate Board Director Changes SEC Filings — March 16, 2026

Across 46 SEC filings on USA Board Room Changes from March 16, 2026, the dominant theme is orderly executive and board transitions, with 25+ resignations/retirements (mostly neutral sentiment, no disagreements cited) balanced by 15+ appointments adding expertise in AI, finance, tech, and operations; CFO turnover is elevated at 12 instances amid retirements and family priorities. Period-over-period trends in the few financial disclosures show mixed results: Dragonfly Energy FY25 revenue +15.8% YoY to $58.6M but net loss widened to $(69.9)M; Kaltura Q4 2025 revenue flat YoY at $45.5M but Adjusted EBITDA +133% to $6.3M; CEA Industries Q3 2026 net loss $(106.6)M driven by 28% BNB price drop. Forward-looking elements include equity grants (Victory Capital $79.4M PSUs, Deere $35M PSUs), CEO successions (KORU July 1, Cerus July 1), and guidance (Dragonfly Q1 2026 rev $9.5M, Kaltura FY26 rev $181-184M). Portfolio-level patterns signal management continuity in insurance/energy/healthcare but potential disruption risks in smaller caps; positive capital allocation via buybacks (Boston Beer $25M) and incentives aligns interests, implying stable conviction despite macro headwinds.

46 high priority 46 total filings
· daily

US Executive Compensation Proxy SEC Filings — March 13, 2026

Across 50 DEF 14A proxy filings, a dominant theme is leadership transitions in 12 companies (e.g., Crane Co, Cigna Group, KB Home, Intuitive Surgical, Bank of Hawaii), signaling board refreshment and succession planning amid strong 2025 performance highlights like record revenues at KB Home ($6.2B+), Ducommun ($824.7M), and ArcBest ($4.0B). Period-over-period trends show bullish outliers including NPS +12% YoY at Republic Bancorp to 73.4 (2.5x bank avg), Berkshire Hathaway +117% 5-yr return vs S&P 500 +96%, Myers Industries stock +72% vs S&P +18%, and GATX rail revenues +6% YoY with $333M NI; however, mixed signals from Edison's 40% CEO comp cuts due to wildfires and Owens Corning auditor fees -24% YoY to $9.8M. Capital allocation trends emphasize shareholder returns ($600M+ at KB Home, $86M at ArcBest), high insider ownership (68% at Rand Capital, 14.6% at Eagle), and governance enhancements like board diversity (55% at Owens Corning). Banking sector (14 filings) largely neutral with board size reductions (Red River to 8), while industrials/homebuilders (8 filings) skew positive with YoY growth. Market implications include proxy vote catalysts in April-May 2026 driving volatility, potential say-on-pay pushback, and opportunities in transitionary firms with aligned comp. Overall sentiment positive/neutral (42/50), with materiality clustered at 6-8/10 for growth leaders.

50 high priority 50 total filings
· daily

US Executive Officer Management Changes SEC — March 13, 2026

Across 39 filings on US executive and director changes from March 13, 2026, a dominant theme is neutral-to-positive leadership stability with 18 resignations/retirements (mostly voluntary, age/policy-related, no disagreements), balanced by 15 new appointments/promotions of experienced executives, particularly CFOs and directors in finance/tech/energy sectors. CFO turnover is elevated (8 cases, including 3 interim appointments), signaling potential transition risks but proactive retention via equity grants/RSUs in 12 companies (e.g., options/RSUs vesting 2026-2028). Shareholder meetings (5 cases) showed strong approvals for directors/auditors but mixed say-on-pay/equity plan votes (e.g., Veru 975k against equity increase, F5 16M against incentive plan), with sentiments neutral (22), positive (10), mixed (4), negative (1), and materiality averaging 6/10. Enriched data reveals positive capital allocation via performance-tied incentives (e.g., USPH 2026 EBITDA targets $101.6M-$108.24M, up from implied prior), hedging supporting dividends (Vitesse 67% 2026 oil hedged at $64-67/Bbl), but limited YoY financial trends due to 8-K focus; no broad margin/revenue declines noted. Portfolio-level, small/mid-caps show higher turnover (25/39), while larger caps emphasize retention bonuses (Waste Management $1M transition bonus). Market implications: monitor CFO transitions for execution risks, but bullish on insider-aligned equity grants signaling conviction amid stable guidance.

39 high priority 39 total filings
· daily

US Corporate Board Director Changes SEC Filings — March 13, 2026

Across 39 filings on USA Board Room Changes from March 13, 2026, a dominant theme is elevated C-suite and board turnover, with 12 CFO/EVP Finance-related changes (resignations in Sprout Social, Waste Management, Wheeler REIT; appointments in CONMED, Hexcel, Orgenesis, Mitesco) signaling potential execution risks amid interim leadership in multiple firms. Director resignations/retirements affected 14 companies (e.g., Nine Energy, Vitesse, Six Flags, Goldman Sachs), often voluntary or age-related, balanced by 10 new appointments of experienced executives/directors (e.g., Avidbank, Hexcel CFO from Axcelis, Cyber App Solutions). Equity incentives surged as retention tools, with grants/RSUs/DCAs in 11 firms (Forward Industries options, Adient $500k RSU, Paymentus RSUs, Optimum $9.375M DCAs), reflecting alignment but mixed AGM votes (Veru 975k against equity plan, F5 16.1M against incentives). No broad YoY/QoQ financial declines noted, but Vitesse's 67% 2026 oil production hedged at $64-67/Bbl supports dividends positively; capital allocation leans toward reinvestment via incentives over buybacks/dividends. Portfolio-level pattern: Higher materiality (7-8/10) events cluster in tech/SaaS (Sprout, Asana) and finance (Waste Mgmt, Avidbank), implying sector-specific leadership refreshes for growth/turnarounds. Market implications: Bullish for firms with proven hires, bearish for abrupt exits without successors, creating near-term volatility opportunities.

39 high priority 39 total filings
· daily

US Executive Compensation Proxy SEC Filings — March 12, 2026

Across 40 DEF 14A proxy filings, a dominant theme is robust 2025 performance justifying executive compensation, with 18 companies (45%) reporting positive YoY revenue/FFO growth (e.g., GE Aerospace +18% revenue to $45.9B, Healthpeak 4% NOI growth), strong capital returns via dividends/buybacks exceeding $2B aggregate (e.g., Avery Dennison $572M repurchases, First Hawaiian $100M repurchases + $250M new program), and high occupancy/dividend yields in REITs (Getty 99.7% occupancy, 3.2% dividend hike). Banks and utilities show resilience with NII growth (First Hawaiian +6.5%) and operational awards (PSEG #1 J.D. Power), while 10 filings (25%) flag mixed sentiment from sales softness (Avery low-single digit label growth) or net losses (Metallus -$1.2M). Board refreshes are prevalent (15+ companies adding/retiring directors), with near-universal say-on-pay and auditor ratification proposals ahead of April-May 2026 meetings. Insider pledges in banks (Citizens 5 execs pledging shares) signal caution, but no widespread selling; pending M&A like NorthWestern-Black Hills adds accretion potential. Portfolio implication: overweight resilient REITs/banks with strong returns, monitor industrials/pharma for tariff/decline impacts.

40 high priority 40 total filings
· daily

US Executive Officer Management Changes SEC — March 12, 2026

Across 39 filings in the USA Executive & Director Changes stream (Mar 12, 2026), a dominant theme is planned CEO and executive successions/transitions in 12 companies (e.g., Build-A-Bear, Blue Ridge Bankshares, Karman Holdings, Angi, Halozyme), often framed positively amid growth or turnarounds, contrasting with abrupt resignations citing concerns in Vestand (2 directors). Board appointments dominate positively (14 instances, e.g., iRhythm, Quest Diagnostics, Colgate-Palmolive) adding healthcare/tech expertise, while retirements are routine (e.g., Arthur J. Gallagher, Matson). Period trends show outliers like TIC Solutions' 39% YoY revenue growth to $1.53B and Adobe's 12% YoY to $6.40B Q1 FY2026, but net losses persist (TIC $87.1M FY2025); equity plan expansions (Enanta +1.6M shares, Analog 95% approval) signal talent retention. Mixed sentiment overall (positive 14, neutral 15, negative/mixed 10), with high materiality CEO/CFO shifts (avg 8/10) implying leadership stability as a portfolio bullish amid M&A/integration (Axcelis-Veeco). Implications: Favor companies with internal/promoted successors and revenue momentum for near-term alpha; monitor banks/tech for transition risks.

39 high priority 39 total filings
· daily

US Corporate Board Director Changes SEC Filings — March 12, 2026

Across 39 SEC filings on USA Board Room Changes (Mar 12, 2026), overarching themes include 18 positive executive/board appointments/resuccessions (e.g., healthcare/tech leaders like Quest Diagnostics adding ex-Walgreens CEO, iRhythm adding UnitedHealth exec), 12 neutral retirements/planned transitions, and 4 negative resignations (e.g., Vestand citing compliance concerns amid ops closures), signaling net board strengthening amid growth strategies. Period-over-period trends show revenue acceleration in outliers like TIC Solutions (+39% FY25 rev YoY to $1.53B, +94% Q4), Adobe (+12% Q1 FY26 rev to $6.40B, subscription +13%), and Build-A-Bear (5th record FY25 at $529.8M), contrasting net losses (TIC -$87.1M improved 28% YoY). Annual meetings largely passed director elections/equity plans (Enanta, Analog Devices, Sanmina, Next Tech >93% support). Critical developments: 7 CEO/CFO transitions (planned successions bullish, sudden departures risky), equity plan expansions (Enanta +1.6M shares despite 22% opposition), debt reductions (B Riley -$37.9M). Portfolio-level: Healthcare (9/39) shows strongest refresh (+ experts from BMS, Tenet, Walgreens), tech/defense maturing via successions; implications favor long-term stability but watch ops risks in consumer/financials.

39 high priority 39 total filings
· daily

US Executive Compensation Proxy SEC Filings — March 11, 2026

Across 30 DEF 14A proxy statements, 2025 financial performance was predominantly strong with 18/30 filings highlighting YoY revenue growth averaging ~7% (e.g., PNC +7%, Levi +7% organic, Genpact +6.6%, Graco +6%), EPS expansion (Ryder +8.4%, Northern Trust +17%, C&F +38%), and robust capital returns including $3.9B shareholder payouts at PNC and $2.4B buybacks at MSCI. Positive sentiment dominates (14/30 filings), driven by innovation, M&A (PNC's FirstBank adding $26B assets post-2025), and expansions (Life Time's 10 new clubs, JNJ's Orthopaedics separation), while mixed/neutral tones appear in flat revenue cases like Valmont (~$4.1B unchanged YoY) and incentive declines (Triumph non-equity -2% YoY). Portfolio-level trends show financials leading with avg net income +20% YoY (PNC +18%, C&F +36%), industrials mixed (Graco sales +6% but TSR flat), and high insider alignment via equity-heavy comp (Triumph CEO stock awards $2.81M driving +31% total pay). Forward-looking catalysts cluster in April-May 2026 AGMs for comp votes (say-on-pay >90% historical approvals like AMETEK 95% avg), auditor ratifications, and director elections amid board refreshes (JNJ adding Pinto/Morikis, Levi chair transition). Capital allocation favors dividends (+5-8% at Smurfit/Graco) and buybacks (Life Time $500M new program), signaling confidence; however, controlled companies (Biglari, Travelzoo) exempt from some governance norms raise minor flags. Overall, bullish for growth names pre-AGM, with watch for say-on-pay risks in mixed comp filers.

30 high priority 30 total filings
· daily

US Executive Officer Management Changes SEC — March 11, 2026

Across 36 filings in the USA Executive & Director Changes stream (March 11, 2026), executive turnover dominates with 18 departures/resignations (e.g., CFOs at Lattice, Bridger, Peloton; Group Presidents at onsemi; CLO at Biogen), mostly neutral sentiment and not due to disagreements, signaling routine transitions amid sector shifts. Positive appointments (9 cases, e.g., experienced CFOs at Navitas/Bridger, Chairman at Mainz Biomed pivoting to Quantum Cyber) outnumber negatives, with compensation enhancements (e.g., PSUs extensions at Target Hospitality, salary hikes at Farmer Mac) in 7 filings indicating retention focus. Limited period-over-period financials show outliers like Tilly's Q4 FY2025 sales +5.3% YoY (comp sales +10.1%) vs FY -2.8%, Atlassian's cloud revenue +25% despite 10% layoffs, and Blue Bird's equity plan expansion +17.3% shares. No widespread insider trading but high CFO churn (5 cases) raises conviction questions; forward-looking catalysts cluster in Q2 2026 (EGMs, annual meetings). Portfolio-level: Neutral-to-positive board refreshments in semis/AI/crypto, potential alpha from undervalued turnarounds but risks from undisclosed details in 5 filings. Overall, low materiality average (5.5/10) suggests limited immediate volatility but monitor transitions for operational hiccups.

36 high priority 36 total filings
· daily

US Corporate Board Director Changes SEC Filings — March 11, 2026

Across 36 SEC filings on USA Board Room Changes from March 11, 2026, a dominant theme is elevated C-suite and board turnover, with 18 departures/resignations/retirements (e.g., CFOs at Peloton, Bridger, Lattice; Presidents at ON Semi, Rayonier) versus 12 new appointments, signaling potential leadership transitions amid sector pressures. Neutral sentiment prevails in 70% of filings, with positive tones on experienced hires in AI/cyber (Mainz Biomed, Navitas, Spire) and mixed in cases like Atlassian's 10% workforce cut despite 25%+ cloud revenue growth. Period-over-period financial trends are sparse but highlight outliers: Tilly's Q4 FY2025 net sales +5.3% YoY to $155.1M with first profitable Q4 since FY2021 ($2.9M NI vs -$13.7M prior), contrasting FY2025 net loss improvement to -$17.5M from -$46.2M. No widespread insider trading data, but capital allocation via incentive plans (e.g., PSIX Phantom Units, Lifeway deferred cash) indicates retention focus. Portfolio-level pattern: Tech/semi sector sees 6/10 filings with finance/legal exits (Lattice CAO, ON Semi President), potentially bearish short-term but bullish on replacements like Navitas CFO. Upcoming catalysts include Mainz EGM (April 2026) and multiple 2026 AGMs.

36 high priority 36 total filings
· daily

US Executive Compensation Proxy SEC Filings — March 10, 2026

A wave of 18 DEF 14A proxy statements filed around March 10, 2026, primarily for virtual annual meetings in late April to early May 2026, highlights robust governance practices across US companies, with universal emphasis on director elections (avg board size 10-13, reductions in USB from 13 to 12 and Roadzen from 7 to 6), advisory say-on-pay votes, and auditor ratifications. Period-over-period trends show pockets of strength (M&T top-quartile 3.67% NIM FY2025, Chemours 56% YoY Opteon sales growth) amid mixed results (Chemours flat $5.8B sales YoY, -3% Adjusted EBITDA to $742M, net loss widened to $386M on $270M+ litigation). Banking sector leads with positive sentiment (USB, M&T) and new Tech/Cyber committees (effective Jan 1, 2026), signaling proactive risk management; tech/industrials emphasize board refreshment (e.g., IBM Ramon Laguarta addition, Whirlpool 5 new independents in 5 years). No widespread insider selling noted, but capital returns persist (Chemours $78M dividends). Portfolio implications: Governance enhancements support long-term stability, but litigation drags (Chemours) and neutral pay-vs-performance disclosures warrant monitoring say-on-pay outcomes for comp alignment risks.

18 high priority 18 total filings
· daily

US Executive Officer Management Changes SEC — March 10, 2026

Across 34 filings in the USA Executive & Director Changes stream (19 new), the dominant theme is board and C-suite transitions, with 15 appointments/promotions (e.g., experienced CFOs at Equinix, Procore) signaling strategic strengthening, 14 neutral resignations/retirements (no disagreements noted), and 5 key CFO departures (Playtika, Xponential, SolarEdge) amid interim placements. Where financial enriched data is available (8/34 filings), revenue trends are robust—avg +37% YoY across Westrock Coffee (+39.8%), Shoulder Innovations (+50%), Virtuix (+41% 9m), Nature's Sunshine (+5.7%)—but margins mixed with compressions (Westrock gross -2%, Shoulder 76.5% vs 77%) and loss widening due to SG&A/R&D investments. Positive forward-looking signals include reaffirmed guidance (Procore FY26, SolarEdge Q1, Xponential FY26) and upbeat outlooks (Westrock 2026 EBITDA +29-44%, Nature's FY26 sales +4-7%). No insider trading patterns, but capital allocation favors retention via salary hikes (Citizens CEO +20%, Cross Country CAO to $340k) and RSU grants. Portfolio implication: Bullish for firms hiring top talent amid growth; monitor CFO churn in high-growth sectors for execution risks. Overall sentiment leans neutral-positive (18 positive/mixed, 14 neutral/negative), with healthcare/tech leading hires.

34 high priority 34 total filings
· daily

US Corporate Board Director Changes SEC Filings — March 10, 2026

Across 34 US SEC filings on board and executive changes dated March 10, 2026, a dominant theme is high turnover in C-suite finance roles, with 9 CFO/CAO/CRO resignations or transitions (e.g., Playtika, NextEra, Xponential, SolarEdge, Equinix) and 7 new appointments (e.g., Harvard Bioscience, Procore, Equinix), signaling potential strategic shifts amid sector pressures. Where financial enriched data is available (7 filings), revenue growth averages +37% YoY (Westrock +39.8%, Shoulder Innovations +50%, Virtuix +41% 9mths, Nature's Sunshine +5.7%), but profitability is mixed with net losses widening in 3/4 cases (Westrock net loss $90.4M vs $80.3M, Shoulder FY loss $40.4M vs $15.6M) and gross margins stable/slightly down (-20bps avg). Positive sentiments prevail in 10/34 filings (29%), driven by experienced hires like Equinix's Olivier Leonetti (30+ yrs exp) and ADM's Michael McMurray, while neutrals dominate resignations (no disagreements noted in 15 cases). Forward-looking guidance in 5 firms shows optimism (Westrock EBITDA +29-44%, Nature's sales +4-7%, Shoulder +31-37%), but CFO searches create near-term uncertainty. Portfolio implications include monitoring finance-heavy sectors (REITs, tech, energy) for execution risks, with board additions enhancing governance in growth firms.

34 high priority 34 total filings
· daily

US Executive Compensation Proxy SEC Filings — March 09, 2026

Across 32 DEF 14A proxy statements, the dominant theme is routine governance with 28/32 filings neutral in sentiment, focusing on director elections, auditor ratifications (e.g., PwC, Deloitte across multiple), and advisory say-on-pay votes, signaling stable board continuity amid no widespread executive pay controversies. A cluster of 13 closed-end funds (Flaherty & Crumrine, Western Asset) shows highly concentrated ownership via Cede & Co. (98-99.97%) and low director/officer holdings (<1%), indicating institutional dominance but limited insider alignment. Limited period-over-period data reveals outliers like Deluxe Corp's 10% YoY growth in Payments/Data segments (to 47% of revenue from 43%), +6% adjusted EBITDA, +10% adjusted EPS, and FCF exceeding $100M target early, reducing leverage to 3.2x; Citizens Financial Group reported top peer TSR in 2025 with $226.4B assets. Mixed sentiments in 4 filings highlight risks in SPACs (5th extension), biotechs (NeuroOne reverse split for Nasdaq compliance, Moleculin 129% dilution from warrants), tempering portfolio optimism. No insider trading activity or capital allocation changes (dividends/buybacks) disclosed across filings, with forward-looking catalysts centered on April 2026 annual meetings (15+ events). Overall, low materiality (avg 5.6/10) suggests muted near-term volatility, but monitor biotech/SPAC dilutions and governance votes for alpha.

32 high priority 32 total filings
· daily

US Executive Officer Management Changes SEC — March 09, 2026

Across 34 SEC filings on USA Executive & Director Changes from March 9, 2026, the dominant theme is proactive board expansions and executive appointments (18 instances, e.g., Phillips 66 added 2 independent directors, FTI named experienced CFO Angela Nam), signaling strengthened governance amid growth phases, contrasted by 12 departures (7 planned retirements like West Pharma CEO Eric Green H2 2026, 5 sudden like Gulfport CEO John Reinhart). Positive sentiment prevails in 14/34 filings (41%), particularly biotech/pharma (Zevra revenue +351% YoY to $106.5M, Boundless R&D -26% YoY to $9.8M Q4), while mixed/neutral in energy transitions. Period trends show cost discipline (Boundless op ex -23% YoY Q4) and revenue surges (FTI FY25 $3.8B, Zevra Q4 +184% YoY), with reaffirmed guidance in West Pharma/Planet Fitness indicating stability. No widespread insider selling; equity grants/bonuses (e.g., Alpha Omega 220% CEO max bonus) reflect alignment. Sector patterns: Energy leadership churn (4/34 filings), biotech hiring for trials/growth. Implications: Bullish for continuity hires, monitor sudden exits for volatility; portfolio-level alpha in pharma turnarounds.

34 high priority 34 total filings
· daily

US Corporate Board Director Changes SEC Filings — March 09, 2026

The 34 filings in the 'USA Board Room Changes' stream reveal a surge in C-suite and board transitions, with 22 CEO/CFO/COO appointments or departures and 12 board additions/resignations, signaling strategic realignments amid growth phases for biotechs and energy firms. Positive sentiments dominate (14/34 filings), driven by experienced hires like FTI Consulting's Angela Nam (scaled revenues 3.5x at prior role) and Mesa Labs' Siddhartha Kadia ($2B business oversight), while mixed/neutral tones accompany sudden exits like Gulfport Energy's CEO Reinhart (materiality 9/10). Period-over-period trends show biotech outperformance: Zevra Therapeutics revenue +351% YoY to $106.5M, Boundless Bio expenses -19% FY YoY with $108M cash to H2 2028; energy firms reaffirm strategies post-changes. No widespread insider selling detected, but capital allocation stable with reaffirmed guidance (Planet Fitness, West Pharma). Portfolio-level pattern: 70% of high-materiality (7+/10) changes are positive/neutral, implying low disruption risk but watch for CEO searches in energy/consulting. Overall, bullish for hires enhancing execution in scaling firms, bearish for leadership vacuums in mature players.

34 high priority 34 total filings
· daily

US Executive Compensation Proxy SEC Filings — March 06, 2026

Across 25 DEF 14A proxy statements filed around March 6, 2026, for April 2026 annual meetings, dominant themes include standard proposals for director elections (all companies), advisory say-on-pay votes (24/25), and auditor ratifications for FY2026 (25/25), with heavy representation from financials/banks (9/25 filings). Period-over-period data highlights record performances in outliers like Unity Bancorp (ROE 18.07%, NIM 4.52%) and Kirby Corp (revenues +3% YoY to $3.4B, EPS +16% to $6.33), contrasted by cost controls (Mobix auditor fees -19.5% YoY) and pay hikes (Boeing CEO +28% to $23.6M amid -3.8% stock drop). Sentiment skews neutral (18/25), with positives in AGNC (559% TSR since IPO vs 264% S&P Financials) and Unity, mixed in high-materiality cases like Boeing, Mobix (Nasdaq reverse split), CDT Equity (80% dilution risk), and Kirby. Portfolio-level trends show margin stability or strength in performers, high insider ownership in Seaboard (74.5%), and capital allocation via dividends (AGNC $15B cumulative). Market implications favor monitoring governance votes for comp alignment amid M&A (Tri Pointe, DataSea) and Nasdaq risks, with alpha in undervalued outperformers pre-meeting catalysts.

25 high priority 25 total filings
· daily

US Executive Officer Management Changes SEC — March 06, 2026

Across 49 SEC filings dated March 6, 2026, focused on USA executive and director changes, a surge in C-suite transitions dominates, with 18 CFO/CAO/accounting officer shifts (e.g., FTAI Aviation, GXO Logistics, PacBio), 15 board appointments/expansions (e.g., PROCEPT BioRobotics, Middleby, Korn Ferry), and 12 departures/resignations (e.g., BiomX CEO, Ashford Hospitality CFO, Planet 13 CAO), signaling portfolio-level leadership refresh amid neutral sentiment (70% neutral, 15% positive, 10% mixed/negative). No explicit YoY/QoQ financial trends emerge due to filing focus, but compensation enhancements in 8 firms (e.g., Workday CEO equity awards up to 547k PVUs, James River CEO incentives doubled to 150%/200%) indicate management retention efforts and conviction. Liberty Media ecosystem shows coordinated CLO transitions to advisor roles (3 filings), while small-caps like 374Water and Vicarious Surgical report terminations/salary cuts amid restructuring/delisting risks. Positive hires emphasize finance/audit expertise (e.g., GXO CFO with 30+ years), potentially bolstering margins/operations, but sudden exits raise governance flags. Implications: Bullish for firms adding proven talent (e.g., MIDD, KFY), bearish for abrupt CFO churn (avg materiality 7/10), with catalysts like annual meetings (May-Jun 2026) and transitions (Apr-Jan 2027) to monitor for stability.

49 high priority 49 total filings
· daily

US Corporate Board Director Changes SEC Filings — March 06, 2026

Across 49 SEC filings on March 6, 2026, focused on USA board room changes, the dominant theme is elevated C-suite turnover, particularly in finance roles with 15+ CFO/CAO transitions, appointments, or departures, amid neutral sentiment (avg materiality 6/10). Positive hires of experienced executives (e.g., ex-CFOs from Shockwave, Deloitte, Spirit AeroSystems) in 12 companies signal strategic refresh for growth/margins, while sudden terminations (e.g., Planet13 CAO, Midland CFO) raise stability concerns. No aggregate period-over-period financial trends disclosed (e.g., revenue YoY, margins QoQ absent), but compensation hikes (e.g., James River CEO STI to 150% base, Workday CEO 547k PVUs) and equity grants indicate management retention focus. Liberty ecosystem (3 filings) shows coordinated CLO transition to advisor role later 2026, neutral impact. Portfolio-level: Small/mid-caps dominate churn (30/49), suggesting governance evolution; watch Q2 2026 for post-transition execution as catalysts.

49 high priority 49 total filings
· daily

US Executive Compensation Proxy SEC Filings — March 05, 2026

Across 12 DEF 14A proxy statements filed around March 5, 2026, a dominant theme is seeking advisory approval on 2025 executive compensation packages, director elections, and auditor ratifications ahead of clustered April 2026 annual meetings, with virtual formats in 11/12 cases. Financial firms like BNY Mellon (178% TSR outperforming S&P Financials 2.5x, 18% annualized EPS growth 2022-2025), First Business Financial (235% 5yr TSR vs peer median 66%, 11% YoY deposit growth), and Publix (superior results with peer-low comp) highlight strong period-over-period performance justifying pay, contrasting neutral filings lacking metrics. Capital allocation shines in PPG Industries ($1.9B op cash flow, $790M buybacks or 3% shares, 54th consecutive dividend hike) amid flat 2% organic sales. Portfolio-level trends show 4/12 with bullish metrics (revenue/EPS/TSR outperformance), mixed in industrials, neutral elsewhere; high prior say-on-pay support (e.g., BNY 95%) signals low dissent risk. Market implications include potential stock boosts post high-vote approvals, governance enhancements via new directors (Publix +1 to 9), and watch for SPAC merger risks in Relativity. Overall, financial sector conviction high, supporting overweight amid 2026 catalysts.

12 high priority 12 total filings